News from the Department of Pharmacy
Vinnova praises SweDeliver in new evaluation
SweDeliver continues to receive top marks for its successful research program and building of new networks and expertise for future drug delivery. This time from main financier Vinnova, emphasizing, among many things, the efficient collaboration that characterizes the competence center.
Swedish Cancer Society allocates SEK 7 million to Sara Mangsbo, Ola Spjuth and Ola Söderberg
Immunotherapy against tumors, Studies of how DNA damage generates cancer cells and Cell profiling in a robotic laboratory are in focus as the Swedish Cancer Society allocates SEK 7.2 million to three promising research projects at the Faculty of Pharmacy.
SRC investing SEK 10 million in research at the Department of Pharmacy
Thomas Dorlo, Lena Friberg and Margareta Hammarlund Udenaes at the Department of Pharmacy receive grants amounting to more than SEK 10 million in the Swedish Research Council's calls in Medicine and Health and Natural Sciences and Engineering in 2022.
Richard Bergström and Siew Chai new honorary doctorates at the Faculty of Pharmacy
The Faculty of Pharmacy is awarding honorary doctorates to Richard Bergström, former national vaccine coordinator, and Siew Chai, Associate Professor at Monash University. The promotion will take place in the Uppsala University Main Auditorium Friday 27 January, 2023.
Nanoparticles pave the way for biological drugs in tablet form
In a new study, researchers at Uppsala University show how specially designed nanoparticles pave the way for oral delivery of biological drugs. "That the particles are absorbed in large quantities in the intestinal cells may facilitate medication for patients that have to inject their biological drug," says Patrik Lundquist, researcher in Drug Delivery.
Numerous new findings by SweDeliver's junior researchers
During summer and autumn, Ires van der Zwaan, Marcus Wanselius, Ann-Christin Jacobsen and numerous other junior researchers at SweDeliver are publishing results that add valuable knowledge to the fields of drug delivery.
SweDeliver receives top marks in new evaluation
SweDeliver fulfills the high expectations and is well equipped to reach its goals, states the Competence Center's Scientific Advisory Board in a new evaluation of the ongoing collaboration between Uppsala University and 16 pharmaceutical companies.
New consortium to develop RNA-based treatment for Crohn's disease
With over 5 million euros in funding from Horizon Europe, new knowledge consortium GENEGUT will develop an RNA-based therapy against inflammatory disease in the gastrointestinal tract. "It is inspiring to take on a challenge with such extensive medical needs," says Per Artursson, Professor of Dosage Form Design.
PhD thesis provides new knowledge about oral delivery of biological drugs
Biological drugs have an increasingly important function in healthcare, but despite numerous years of research, physicians often lack effective methods to give them as tablets. In a current PhD thesis, Staffan Berg presents new knowledge about how permeation enhancers and correct release profile can increase the absorption of biological drugs in the blood when delivered orally.
Sara Mangsbo receives the BiotechBuilders Award
“Receiving the BiotechBuilders Award 2022 provides valuable inspiration and hopefully contributes to consolidating Uppsala's and Biopharmaceutical’s places on the Swedish Life Science map,” states Sara Mangsbo, research director in immuno-oncology at Uppsala University.
Popular summer school in Pharmacometrics continues to expand
“This is the best course I have taken during my entire PhD,” states a participant at the Uppsala Pharmacometrics Summer School, every August gathering doctoral students from all over the world. "This year's summer school is our biggest to date," says Mats Karlsson, Professor of Pharmacometrics.
Uppsala University ranks 23rd in the world in Pharmacy & Pharmaceutical Sciences
The 2022 Academic Ranking of World Universities is official: Uppsala University continues to climb in the field of Pharmacy & Pharmaceutical Sciences and now ranks 23rd in the world. "This is yet another acknowledgment that our determined work is fruitful," states Mathias Hallberg, Dean at the Faculty of Pharmacy.
Antibiotic researchers of the future at Uppsala summer school
Antibiotic resistance, Innovations and Design Thinking were on the agenda when the Faculty of Pharmacy welcomed young researchers from six European universities to the TIPAT Summer School 2022. "Organizing an event like this generates great values," says Iris Minichmayr at the Department of Pharmacy.
Translational PKPD conference arousing international interest
September 14-15, the conference Translating PKPD - (Retro)Perspectives brings the world of Pharmacokinetics and Pharmacodynamics to Uppsala University. "It is inspiring to welcome such a significant part of our scientific field,” says Irena Loryan at the Faculty of Pharmacy.
Registration is now open for the 12th Uppsala University Symposium on Pharmaceutical Profiling in Drug Discovery and Development
We are happy to announce that the registration to the 12th Uppsala University Symposium on Pharmaceutical Profiling in Drug Discovery and Development is now open.
Madlen Hubert becomes newly promoted Associate Professor!
We would like to congratulate Madlen Hubert for being promoted to Associate Professor (docent)! Very well done and a hard-earned achievement!
Madlen Hubert receives grant from the Valborg Jacobsons fond
The Valborg Jacobsons fond supports Madlen’s research with a grant of 200’000 SEK to develop human gut models for improved prediction of the in vivo performance of advanced oral medicines. Congratulations!
Now hiring: Two PhD Students in Molecular Pharmaceutics
SweDeliver is now recruiting two PhD Students in Molecular Pharmaceutics. Welcome to submit your application no later than 18 February 2022.
***Update – Symposium will be held online***
The 11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development on January 27, 2022 will be held as a virtual meeting! Don’t miss to register before Jan 13.
New article from the group was selected as today's ACS American Chemical Society Editors' Choice!
The new article by Rosita Kneiszl, Shakhawath Hossain and Per Larsson was selected as today's ACS (American Chemical Society) Editors' Choice among articles from +60 peer-reviewed journals.
Inaugural lecture of Prof. Bergström
Prof. Christel Bergström gave her inaugural lecture November 16, 2021. The video is now available.
The registration for the upcoming 11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development on January 27, 2022 is now open
The registration for the upcoming 11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development on January 27, 2022 is now open.
Alexandra Teleki was recognised as an outstanding early career scientist by JPharmSci
The Editorial Staff and the American Pharmacists Association are for the first time choosing outstanding early career scientists for publishing their most original and significant scientific findings in the Journal of Pharmaceutical Sciences(JPharmSci®) in 2021. Alexandra Teleki is one of the ten researchers who were recognised worldwide! Congratulations!
Quality Abstract Award to Anders Thorsted
Anders Thorsted recieved the Trainee Qualtiy Abstract Award at The American Conference of Pharmacometrics earlier this month.
1st Prize in the Young Investigator Session at ISAP to Vicent Aranzana-Climent
During Young Investigator Session of the International Society of Anti-infective Pharmacology, Vincent Aranzana-Climent was awarded the 1st prize for his work!
Two of our colleges were elevated to ISoP Fellows
It's with great joy and pride that we can announce that Prof. Lena Friberg and Dr. Siv Jönsson has been elevated to ISoP Fellows this year.
***SAVE THE DATE*** 11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development on January 27, 2022
We are delighted to announce the date for the upcoming Symposium on Pharmaceutical Profiling in Drug Discovery and Development on January 27, 2022 in Uppsala, Sweden. Keynote speakers and registration details will be announced shortly.
Per Artursson, Christel Bergström, Madlen Hubert and Pawel Baranczewski
Drug Delivery Group, Department of Pharmacy, Uppsala University
Seminar by Cecilia Stålsby Lundborg
"Without effective antibiotics, health care as we know it will not exist anymore!"
Don't miss unique opportunity of interacting with one of the leading researchers in global health: Cecilia Stålsby Lundborg, Professor at Karolinska Institutet.
They receive the Pharmaceutical Student Union's pedagogical awards
“Receiving the students' award after this challenging year feels extra great", says Lecturer Christina Wedén who, together with Ulrika Rosenström and Viktor Rognås, receive the Pharmaceutical Student Union's 2021 pedagogical awards.
Now hiring: PhD student for project on oral delivery of antibiotics
The research group Molecular Pharmaceutics are looking to recruit a PhD student for a project to develop a generic nanosized drug delivery platform for optimal absorption of antibiotics with minimal intestinal side effects.
Now hiring: Researcher in molecular pharmaceutics
SweDeliver is recruiting a researcher in molecular pharmaceutics for the project Structural characterization of formulated macromolecular drugs with lipids in response to dilution, digestion and permeation. Submit your application no later than 16 April 2021.
Now hiring: Post-doc for project about lipid nanoparticles for oral drug delivery
The BLT group is looking for new postdoctoral researcher. Join our multidisciplinary team as a post-doc focusing on lipid nanoparticles for oral drug delivery.
See advertisement for details, apply before 30 April 2021.
Drug Delivery Group paper highlighted in J Pharm Sci's "Most Original and Most Significant Scientific Findings"
The Journal of Pharmaceutical Sciences has highlighted the original research article titled "Proteomics-Informed Identification of Luminal Targets For In Situ Diagnosis of Inflammatory Bowel Disease" in their quartely summary of "Most Original and Most Significant Scientific Findings".
The article is authored by Shno Asad, Christine Wegler, David Ahl, Christel A.S. Bergström, Mia Phillipson, Per Artursson and Alexandra Teleki.
Summary of the completed "Intestinanos" project published on CORDIS
"Understanding what happens in the gut is crucial to the success of oral medications"
Read more about the ERC financed (completed) "Intestinanos" project here: https://cordis.europa.eu/article/id/429242-building-virtual-intestine-to-fine-tune-the-formulations-of-new-drugs
Visit the Department of Pharmacy virtual booth at this year's SciFest exhibition
Get to know more about the research we do & learn more about oral drug delivery! Check our virtual lab, pharmacy quiz & activities around nanoparticles in collaboration with Georgios A. Sotiriou's lab at KI.
Watch the trailer for our Virtual Lab https://lnkd.in/dE-mjGw.
11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development postponed to January 2022
The upcoming 11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development at Uppsala University is postponed to January 2022 due to current pandemic situation.
Are you interested in a summer research project?
Are you interested in joining our team for a summer research project? Apotekarsocieteten has scholarships supporting 5-7 weeks of research studies. Reach out to us to discuss interesting project ideas! Dead-line for application is Jan 31.
Alexandra Teleki awarded ERC Consolidator Grant
Alexandra Teleki has been awarded an ERC Consolidator Grant for her project MAGNETO. She and her team will use functional nanoparticles to develop novel diagnostic and therapeutic methods to treat inflammatory bowel disease in children.
16.68 million to research at the pharmaceutical faculty.
Per Artursson, Olof Eriksson, Hans Lennernäs and Ola Spjuth are granted 16.68 million from the Swedish research Swedish Research Council for research involving medicine and health. The grant will be received during 2020 and four years ahead.
Professor Per Artursson: Giant of Pharmaceutical Sciences
Professor Per Artursson appointed Giant of Pharmaceutical Sciences by the Journal of Pharmaceutical Sciences, which is the world's oldest pharmaceutical journal.
PhD-student position for project regarding the impact of drug exposure in the human colon
We are looking for applicants for a PhD student project within the COLOTAN network. The focus of the project is investigating the relationship between free and bound drug concentrations, local drug exposure and systemic drug delivery in the colon. Read more about the position here: https://mp.uu.se/en/web/info/vart-uu/lediga-jobb/-/jobb/358445
PhD-student position for project regarding importance of diffusion, dissolution and release mechanisms for dosage forms delivering drugs to the colonic environment
We are looking for applicants for a PhD student project within the COLOTAN network. The focus of the project is on dissolution, diffusion and release mechanisms in the colonic fluid. Read more in the advertisement here: https://mp.uu.se/en/web/info/vart-uu/lediga-jobb/-/jobb/358581.
Maria Karlgren receives the 2020 IQ Consortium and AAALAC International Global 3Rs Award
Maria Karlgren has received the 2020 IQ Consortium and AAALAC International Global 3Rs Award based on the scientific research paper “A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.”
New model to provide more accurate predictions in drug treatment
With a new and more accurate computational model for how the drug rosuvastatin (Crestor ®) is taken up and eliminated in the liver, researchers at Uppsala University paves the way for more efficient drug development and future treatment methods.
New method enables earlier answers during drug development
With the Nobel Prize-winning technology CRISPR-Cas9, researchers at Uppsala University are creating new components for more efficient drug development with fewer animal experiments.
Continued funding for project “Personalized medications for children suffering from severe diseases”
We are very delighted to receive the news that the Family Erling Persson Foundation will continue to support our project on “Personalized medications for children suffering from severe diseases”. This is a fantastic collaborative project between our group, Prof Maria Strømme´s group at the Ångström laboratory and the Children’s Hospital in Uppsala.
Project grant for development of pedagogical online learning awarded to Per Larsson
Assistant Professor Per Larsson has been granted project funds for development of online learning methods.
Artursson and Bergström groups donate PPE to Uppsala University Hospital
The Artursson and Bergström group have together donated personal protective equipment (PPE) including safety glasses, mouth protection and 12,500 gloves to assist the staff at the Uppsala University Hospital during the Covid-19 pandemic.